Globus Medical Features Latest Innovative Technologies at Scoliosis Research Society’s International Meeting on Advanced Sp...
July 11 2018 - 11:15AM
Globus Medical, Inc. (NYSE:GMED), a leading musculoskeletal
solutions company, will showcase its advanced technologies at the
Scoliosis Research Society’s (SRS) 25th Annual International
Meeting on Advanced Spine Techniques (IMAST) being held July 11-14,
2018, in Los Angeles, California. The company will also
highlight its robotics platform technology through an industry
workshop at IMAST, ExcelsiusGPS® First Clinical Experiences,
featuring its revolutionary robotic guidance and navigation system
on July 13 from 12:00-1:00 pm led by Dr. Jeffrey A. Goldstein,
Chief of Spine Service for Education and Director of the Spine
Fellowship at NYU Langone Orthopedic Hospital.
“We recognize SRS as one of the world’s premier spine societies
whose mission is critical to improving the lives of patients with
spinal deformities,” said Andrew Iott, Senior Vice President Global
Product Development. “As leaders in the musculoskeletal
device industry, we are committed to supporting the research,
education, and development of medical advancements in the field of
spinal deformity. We are particularly proud to be a sponsor
of IMAST as well as support the continued mission of SRS.”
With over 180 products launched to date, Globus Medical has one
of the most comprehensive portfolios of expandable technology in
the industry. With over 12 years of experience developing
expandable interbody spacer systems, combined with a track record
of success, Globus has developed next generation implants that
provide innovative solutions to maximize lordosis and address
sagittal imbalance.
About Globus Medical, Inc.Globus Medical, Inc.
is a leading musculoskeletal solutions company based in Audubon,
PA. The company was founded in 2003 by an experienced team of
professionals with a shared vision to create products that enable
surgeons to promote healing in patients with musculoskeletal
disorders. Additional information can be accessed
at http://www.globusmedical.com.
Safe Harbor StatementsAll statements included
in this press release other than statements of historical fact are
forward-looking statements and may be identified by their use of
words such as “believe,” “may,” “might,” “could,” “will,” “aim,”
“estimate,” “continue,” “anticipate,” “intend,” “expect,” “plan”
and other similar terms. These forward-looking statements are based
on our current assumptions, expectations and estimates of future
events and trends. Forward-looking statements are only predictions
and are subject to many risks, uncertainties and other factors that
may affect our businesses and operations and could cause actual
results to differ materially from those predicted. These risks and
uncertainties include, but are not limited to, factors affecting
our quarterly results, our ability to manage our growth, our
ability to sustain our profitability, demand for our products, our
ability to compete successfully (including without limitation our
ability to convince surgeons to use our products and our ability to
attract and retain sales and other personnel), our ability to
rapidly develop and introduce new products, our ability to develop
and execute on successful business strategies, our ability to
comply with changing laws and regulations that are applicable to
our businesses, our ability to safeguard our intellectual property,
our success in defending legal proceedings brought against us,
trends in the medical device industry, general economic conditions,
and other risks. For a discussion of these and other risks,
uncertainties and other factors that could affect our results, you
should refer to the disclosure contained in our most recent annual
report on Form 10-K filed with the Securities and Exchange
Commission, including the sections labeled “Risk Factors” and
“Cautionary Note Concerning Forward-Looking Statements,” and in our
Forms 10-Q, Forms 8-K and other filings with the Securities and
Exchange Commission. These documents are available at www.sec.gov.
Moreover, we operate in an evolving environment. New risk factors
and uncertainties emerge from time to time and it is not possible
for us to predict all risk factors and uncertainties, nor can we
assess the impact of all factors on its business or the extent to
which any factor, or combination of factors, may cause actual
results to differ materially from those contained in any
forward-looking statements. Given these risks and uncertainties,
readers are cautioned not to place undue reliance on any
forward-looking statements. Forward-looking statements contained in
this press release speak only as of the date of this press release.
We undertake no obligation to update any forward-looking statements
as a result of new information, events or circumstances or other
factors arising or coming to our attention after the date
hereof.
Contact:Brian KearnsVice President, Business
Development and Investor RelationsPhone: (610) 930-1800Email:
investors@globusmedical.comwww.globusmedical.com
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Aug 2024 to Sep 2024
Globus Medical (NYSE:GMED)
Historical Stock Chart
From Sep 2023 to Sep 2024